UAE Organ Transplant Immunosuppressant Drugs Market Size & Outlook
UAE organ transplant immunosuppressant drugs market, 2016-2027 (US$M)
Related Markets
UAE organ transplant immunosuppressant drugs market highlights
- The UAE organ transplant immunosuppressant drugs market generated a revenue of USD 14.1 million in 2020 and is expected to reach USD 18.2 million by 2027.
- The UAE market is expected to grow at a CAGR of 3.7% from 2021 to 2027.
- In terms of segment, calcineurin inhibitors was the largest revenue generating drug class in 2020.
- Calcineurin Inhibitors is the most lucrative drug class segment registering the fastest growth during the forecast period.
Organ transplant immunosuppressant drugs market data book summary
| Market revenue in 2020 | USD 14.1 million |
| Market revenue in 2027 | USD 18.2 million |
| Growth rate | 3.7% (CAGR from 2020 to 2027) |
| Largest segment | Calcineurin inhibitors |
| Fastest growing segment | Calcineurin Inhibitors |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Calcineurin Inhibitors, Antiproliferative Agents, MTOR Inhibitor, Steroids, Antibodies |
| Key market players worldwide | Astellas Pharma Inc, Sanofi SA, Novartis AG ADR, Dr Reddy's Laboratories Ltd ADR, Roche, GlaxoSmithKline, Asahi Kasei Corp, Bristol-Myers Squibb Co, Accord Healthcare, Viatris Inc |
Other key industry trends
- In terms of revenue, UAE accounted for 0.3% of the global organ transplant immunosuppressant drugs market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Middle East & Africa, Saudi Arabia organ transplant immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 74.4 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Organ Transplant Immunosuppressant Drugs Market Scope
Organ Transplant Immunosuppressant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE organ transplant immunosuppressant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to organ transplant immunosuppressant drugs market will help companies and investors design strategic landscapes.
Calcineurin inhibitors was the largest segment with a revenue share of 51.06% in 2020. Horizon Databook has segmented the UAE organ transplant immunosuppressant drugs market based on calcineurin inhibitors, antiproliferative agents, mtor inhibitor, steroids, antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
- UAE Organ Transplant Immunosuppressant Drugs Drug Class Outlook (Revenue, USD Million, 2016-2027)
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitor
- Steroids
- Antibodies
- UAE Organ Transplant Immunosuppressant Drugs Transplant Outlook (Revenue, USD Million, 2016-2027)
- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Other
- UAE Organ Transplant Immunosuppressant Drugs Distribution Channel Outlook (Revenue, USD Million, 2016-2027)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Reasons to subscribe to UAE organ transplant immunosuppressant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE organ transplant immunosuppressant drugs market databook
-
Our clientele includes a mix of organ transplant immunosuppressant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE organ transplant immunosuppressant drugs market, including forecasts for subscribers. This country databook contains high-level insights into UAE organ transplant immunosuppressant drugs market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
UAE organ transplant immunosuppressant drugs market size, by drug class, 2016-2027 (US$M)
UAE Organ Transplant Immunosuppressant Drugs Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
